Is immediate transverse rectus abdominis musculocutaneous flap reconstruction associated with improved cancer-specific survival in locally advanced breast cancer?
Immediate TRAM flap reconstruction is oncologically safe and is unassociated with delayed adjuvant therapies or delayed detection of local recurrence. Patients with locally advanced breast cancer can be considered appropriate candidates for TRAM flap reconstruction because the procedure is an independent predictor of breast cancer survival and is associated with a 76.5% decrease (HR, 0.235) in the risk of cancer death.
CD patients with active disease display clinical pulmonary dysfunction compared with those in remission.